Dupont Capital Management Corp grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 30.6% in the 4th quarter, Holdings Channel reports. The firm owned 148,107 shares of the healthcare conglomerate’s stock after acquiring an additional 34,659 shares during the quarter. UnitedHealth Group accounts for approximately 0.7% of Dupont Capital Management Corp’s investment portfolio, making the stock its 14th biggest holding. Dupont Capital Management Corp’s holdings in UnitedHealth Group were worth $32,652,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Exane Derivatives grew its stake in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after acquiring an additional 460 shares during the period. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter worth $114,000. Acrospire Investment Management LLC grew its stake in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the period. Jacobi Capital Management LLC grew its stake in shares of UnitedHealth Group by 6.6% during the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock worth $136,000 after acquiring an additional 45 shares during the period. Finally, Regal Wealth Group Inc. grew its stake in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after acquiring an additional 3 shares during the period. 85.87% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have recently weighed in on UNH shares. Cantor Fitzgerald reiterated a “buy” rating and set a $225.00 price target on shares of UnitedHealth Group in a research note on Monday, November 27th. Jefferies Group restated a “buy” rating and issued a $248.00 target price on shares of UnitedHealth Group in a research note on Friday, December 1st. Deutsche Bank raised their target price on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Royal Bank of Canada raised their target price on UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Oppenheimer raised their target price on UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 29th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $245.14.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the company posted $2.11 EPS. sell-side analysts forecast that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be issued a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.33%. UnitedHealth Group’s dividend payout ratio is 31.58%.
In related news, Director Richard T. Burke sold 10,400 shares of the firm’s stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $229.87, for a total transaction of $2,390,648.00. Following the transaction, the director now directly owns 1,781,657 shares of the company’s stock, valued at approximately $409,549,494.59. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,196 shares of company stock worth $12,291,179. 0.89% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Inc (UNH) Shares Bought by Dupont Capital Management Corp” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://sportsperspectives.com/2018/03/10/unitedhealth-group-inc-unh-shares-bought-by-dupont-capital-management-corp.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.